Patrick Rüdelsheim

Obtained his PhD in biology/botany at the University of Antwerp, Belgium.

He started his career in D.J. Vanderhave B.V., a Dutch Seed company where he was involved in the application of plant cell biology in classical breeding. In 1990, he joined Plant Genetic Systems N.V., Ghent, Belgium as Field Trial Supervisor. After being in charge of Product Development and Registration, he was appointed Director Regulatory Affairs and Member of the PGS Board. In 1996, following the acquisition of PGS by AgrEvo, he became Global Head of Biotechnology Regulatory Affairs for the AgrEvo group. In this function, he ensured the scientific argumentation for Product Safety and Quality as well as the compliance with all regulatory acquirements related to genetic engineering. After the creation of Aventis S.A. due to the merger of Hoechst and Rhône-Poulenc, Patrick Rüdelsheim became Global Head Regulatory Affairs BioScience of Aventis CropScience and following the acquisition of Aventis CropScience by Bayer in 2002, he was confirmed in that position for Bayer CropScience.

In 2003, he founded and became General Partner of Perseus BVBA, a service company focused on bio-safety and related regulatory requirements. Since medio 2015, he is Senior Regulatory Advisor for ABS-int, a multi-disciplinary initiative dedicated to Access and Benefit Sharing requirements. He lectures at the University of Ghent and the University of Antwerp; and is an active member of several professional organisations (ISBR, EBSA, EFB, BBP,